BioSpace News Archive

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced the initiation of its Phase 1 clinical trial of Voriconazole Inhalation Powder

Eko, a digital health company with an AI-powered cardiac screening platform, today announced the second generation of its CORE product line

The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

TKE’s commitment to raise $10 million for St. Jude in 10 years was announced in August and is the third and largest commitment TKE has made to the hospital since the partnership began in 1978.

Since 2006, Dr. med Cynthia A. Wolfensberger has been practicing at the Römerhof where she works with renowned heart specialist Dr. med. Shlomo Ashkenazy.

In 2019, the on-body wearable injectors segment had a significant market share, and this trend is expected to continue over the forecast period.

Collaboration will Target a Therapeutic Approach for Treating Asthma and Allergic Diseases

RSI-MRI+ imaging software utilizes an advanced diffusion MRI technique, biophysical models, and artificial intelligence to increase the visibility of restricted water, a hallmark feature of cancerous tissue.

The deal marks the fourth acquisition for the pharmaceutical services provider in the past thirteen months

The global ambulatory surgical and emergency centers market size is expected to reach around US$ 203.1 Bn by 2026, Predict by Acumen Research and Consulting